This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sigma-Tau Research Switzerland S.a.. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Serena Ferrini: Innovator in Antitumoural Compounds
Introduction
Serena Ferrini is a notable inventor based in Gracciano di Colle Val d'Elsa, Italy. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with antitumoural activity. Her work focuses on innovative solutions to combat cancer and other diseases.
Latest Patents
Serena Ferrini holds a patent for "Aryl triazole compounds with antitumoural activity." This invention relates to aryl triazole derivatives of Formula I, which exhibit antitumoural properties by targeting the molecular chaperone heat shock protein 90 (Hsp90). The patent outlines the use of these compounds in medicine, specifically for cancer treatment and other diseases responsive to Hsp90 inhibition.
Career Highlights
Ferrini is currently associated with Sigma-Tau Research Switzerland S.A., where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of Hsp90 and its role in cancer biology.
Collaborations
Throughout her career, Serena has collaborated with esteemed colleagues such as Giuseppe Giannini and Walter Cabri. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Serena Ferrini's contributions to the field of antitumoural compounds highlight her dedication to advancing medical science. Her innovative work continues to pave the way for new treatments in the fight against cancer.